A citation-based method for searching scientific literature

Abby B Statler, Wei Wei, Annie Gupta, Cassann N Blake, Brian P Hobbs, Zeina A Nahleh. Clin Breast Cancer 2020
Times Cited: 1

List of co-cited articles
articles co-cited >1

Times Cited
  Times     Co-cited

Breast cancer statistics, 2019.
Carol E DeSantis, Jiemin Ma, Mia M Gaudet, Lisa A Newman, Kimberly D Miller, Ann Goding Sauer, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2019

Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources.
Tomi Akinyemiju, Justin Xavier Moore, Akinyemi I Ojesina, John W Waterbor, Sean F Altekruse. Breast Cancer Res Treat 2016

The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches.
Dorien Lobbezoo, Wilfred Truin, Adri Voogd, Rudi Roumen, Gerard Vreugdenhil, Marcus Wouter Dercksen, Franchette van den Berkmortel, Tineke Smilde, Agnes van de Wouw, Roel van Kampen,[...]. Oncotarget 2016

Neoadjuvant chemotherapy: not the best option in estrogen receptor-positive, HER2-negative, invasive classical lobular carcinoma of the breast?
Arnie Purushotham, Sarah Pinder, Massi Cariati, Mark Harries, Aron Goldhirsch. J Clin Oncol 2010

Therapeutic strategies for breast cancer based on histological type.
Futoshi Akiyama, Rie Horii. Breast Cancer 2009

An overview of prognostic factors for long-term survivors of breast cancer.
Isabelle Soerjomataram, Marieke W J Louwman, Jacques G Ribot, Jan A Roukema, Jan Willem W Coebergh. Breast Cancer Res Treat 2008

Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support.
F R Dunphy, G Spitzer, J E Fornoff, J C Yau, S D Huan, K A Dicke, A U Buzdar, G N Hortobagyi. Cancer 1994

The National Cancer Data Base: a powerful initiative to improve cancer care in the United States.
Karl Y Bilimoria, Andrew K Stewart, David P Winchester, Clifford Y Ko. Ann Surg Oncol 2008

US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
Nadia Howlader, Sean F Altekruse, Christopher I Li, Vivien W Chen, Christina A Clarke, Lynn A G Ries, Kathleen A Cronin. J Natl Cancer Inst 2014

Relationship of histologic grade and histologic subtype with oncotype Dx recurrence score; retrospective review of 863 breast cancer oncotype Dx results.
Kamaljeet Singh, Xin He, Elizabeth T Kalife, Shahrzad Ehdaivand, Yihong Wang, C James Sung. Breast Cancer Res Treat 2018

Breast Carcinoma: Updates in Molecular Profiling 2018.
Sudeshna Bandyopadhyay, Martin H Bluth, Rouba Ali-Fehmi. Clin Lab Med 2018

Time to initial cancer treatment in the United States and association with survival over time: An observational study.
Alok A Khorana, Katherine Tullio, Paul Elson, Nathan A Pennell, Stephen R Grobmyer, Matthew F Kalady, Daniel Raymond, Jame Abraham, Eric A Klein, R Matthew Walsh,[...]. PLoS One 2019

Outcome of special types of luminal breast cancer.
M Colleoni, N Rotmensz, P Maisonneuve, M G Mastropasqua, A Luini, P Veronesi, M Intra, E Montagna, G Cancello, A Cardillo,[...]. Ann Oncol 2012

Real-world Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysis.
Abby B Statler, Brian P Hobbs, Wei Wei, Annie Gupta, Cassann N Blake, Zeina A Nahleh. Sci Rep 2019

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.